No Data
Psyence Group Closes Disposal of PsyLabs Stake; Shares Fall
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Press Release: Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group's Stake in PsyLabs
Psyence Biomedical Shares Are Trading Higher After the Company Announced the Recruitment of Its Australia-based Empax Center as the Second Trial Site for Psyence's Biomed Ongoing Phase IIb Clinical Trial of Nature-derived Psilocybin as a Potential...
Express News | Psyence Biomedical Ltd - Biomed to Announce Topline Data in H2 2025
Express News | Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase Iib Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
No Data
No Data